BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1325863)

  • 1. Effects of sympathetic stimulation on use dependence of lidocaine, mexiletine, and quinidine in an intact canine model.
    Newman D; Herre JM; Chin M; Scheinman MM; Franz M; Katzung B
    Can J Physiol Pharmacol; 1992 Feb; 70(2):219-24. PubMed ID: 1325863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
    Costard-Jäckle A; Franz MR
    J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
    Roden DM; Iansmith DH; Woosley RL
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency- and orientation-dependent effects of mexiletine and quinidine on conduction in the intact dog heart.
    Bajaj AK; Kopelman HA; Wikswo JP; Cassidy F; Woosley RL; Roden DM
    Circulation; 1987 May; 75(5):1065-73. PubMed ID: 2436827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo.
    Costard-Jaeckle A; Liem LB; Franz MR
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):810-7. PubMed ID: 2481766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolongation of the QT interval by dofetilide modulates rate-dependent effects of mexiletine on intraventricular conduction.
    Todt H; Zojer N; Raberger G; Schütz W
    Eur J Pharmacol; 1994 Nov; 265(1-2):43-52. PubMed ID: 7883028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency-dependent effects of several class I antiarrhythmic drugs on Vmax of action potential upstroke in canine cardiac Purkinje fibers.
    Varro A; Elharrar V; Surawicz B
    J Cardiovasc Pharmacol; 1985; 7(3):482-92. PubMed ID: 2410678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative electropharmacology of mexiletine, lidocaine and quinidine in a canine Purkinje fiber model.
    Burke GH; Loukides JE; Berman ND
    J Pharmacol Exp Ther; 1986 Apr; 237(1):232-6. PubMed ID: 3958966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action potential prolongation and induction of abnormal automaticity by low quinidine concentrations in canine Purkinje fibers. Relationship to potassium and cycle length.
    Roden DM; Hoffman BF
    Circ Res; 1985 Jun; 56(6):857-67. PubMed ID: 4006095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electropharmacologic synergism with mexiletine and quinidine.
    Duff HJ; Kolodgie FD; Roden DM; Woosley RL
    J Cardiovasc Pharmacol; 1986; 8(4):840-6. PubMed ID: 2427827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction.
    Feld GK; Venkatesh N; Singh BN
    Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Na+ channel blockers on extrasystolic stimulation-evoked changes in ventricular conduction and repolarization.
    Osadchii OE
    J Cardiovasc Pharmacol; 2014 Mar; 63(3):240-51. PubMed ID: 24220314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents.
    Vanoli E; Priori SG; Nakagawa H; Hirao K; Napolitano C; Diehl L; Lazzara R; Schwartz PJ
    J Am Coll Cardiol; 1995 Jun; 25(7):1609-14. PubMed ID: 7759713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of simultaneous administration of mexiletine and quinidine on the electrophysiologic parameters of canine Purkinje fibers.
    Burke GH; Loukides JE; Berman ND
    J Cardiovasc Pharmacol; 1986; 8(6):1138-43. PubMed ID: 2434738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of quinidine in the mexiletine-quinidine interaction: electrophysiologic correlates of enhanced antiarrhythmic efficacy.
    Duff HJ; Rahmberg M; Sheldon RS
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):685-92. PubMed ID: 1703588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of lidocaine and quinidine on impulse propagation across the canine Purkinje-muscle junction during combined hyperkalemia, hypoxia, and acidosis.
    Evans JJ; Gilmour RF; Zipes DP
    Circ Res; 1984 Aug; 55(2):185-96. PubMed ID: 6744528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhomogeneity of ventricular refractory period in canine heart with quinidine-induced long QT interval: a comparative study on effects of heart rate, isoprenaline, and lignocaine.
    Inoue H; Toda I; Nozaki A; Matsuo H; Mashima S; Sugimoto T
    Cardiovasc Res; 1985 Oct; 19(10):623-30. PubMed ID: 4053138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of ventricular action potential due to sympathetic stimulation.
    Murayama M; Harumi K; Mashima S; Shimomura K; Murao S
    Jpn Heart J; 1977 Mar; 18(2):259-65. PubMed ID: 870733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of quinidine on the transmembrane potentials of young and adult canine cardiac Purkinje fibers.
    Morikawa Y; Rosen MR
    J Pharmacol Exp Ther; 1986 Mar; 236(3):832-7. PubMed ID: 3950873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate-dependent effects of lidocaine on His-Purkinje conduction in the intact neonatal heart--characterization and amplification by N-acetylprocainamide.
    Dise TL; Stolfi A; Clarkson CW; Pickoff AS
    J Pharmacol Exp Ther; 1991 Nov; 259(2):535-42. PubMed ID: 1719192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.